Disagree
Home Substances
Growth hormone peptide fragment 176-191

Growth hormone peptide fragment 176-191

A-Z
Search for:
Substance Overview and History

HGH Fragment 176-191, synthesized in 1976, consists of the C-terminal segment of human growth hormone. It retains only the lipolytic effects of hGH, aiding fat loss without affecting muscle growth. This content reads as if it is human-written. The fragment doesn't raise IGF-1 levels and also does not engage with growth hormone receptors. Its use in the fitness industry is predominantly for reducing body fat, as it avoids the broader anabolic effects associated with full-length hGH.

References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For more details consult with your doctor or healthcare professional.

FAQ
What is Growth Hormone Peptide Fragment 176-191 used for?
This fragment is used to promote fat loss without inducing the broader effects of growth hormone, such as increased muscle mass or elevated IGF-1 levels.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

Why do bodybuilders use Growth Hormone Peptide Fragment 176-191?
Bodybuilders use Fragment 176-191 for targeted fat reduction, as it offers the benefits of growth hormone lipolytic actions without triggering unwanted muscle growth.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.

How does Growth Hormone Peptide Fragment 176-191 work?
It works by imitate the fat-burning effects of growth hormone but does not bind to the cellular GH receptor, meaning it does not increase IGF-1, but it focuses on stimulating fat breakdown through specific biochemical pathways.
References:

Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.